Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Shares Down 2.5% - Here's What Happened

What Are Wall Street Analysts' Target Price for AbbVie Stock?

AbbVie Earnings: Maintaining Our Fair Value Estimate Following a Steady Second Quarter | Morningstar

AbbVie (NYSE:ABBV) Given New $285.00 Price Target at Cantor Fitzgerald - Markets Daily

AbbVie (NYSE:ABBV) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

3 Top Dividend Stocks to Buy Before Their Next Payout

Sapient Capital LLC Has $44.56 Million Stake in AbbVie Inc. $ABBV

Best Pharmaceutical Stocks To Follow Today - August 2nd - Markets Daily

ABBV Stock: Q2 Dip Is a Buying Opportunity With $300 Ahead

AbbVie Quietly Solved Its Biggest Problem-Now What?

Best Biotech Stocks To Add to Your Watchlist - August 2nd - Stock Observer

Flagship Wealth Advisors LLC Reduces Stock Holdings in AbbVie Inc. $ABBV

First Nebraska Trust Co Buys Shares of 7,118 AbbVie Inc. $ABBV

Financial Solutions Advisory Group Inc. Purchases New Stake in AbbVie Inc. $ABBV - Markets Daily

9,761 Shares in AbbVie Inc. $ABBV Purchased by Financial Solutions Advisory Group Inc.

AbbVie (NYSE:ABBV) Shares Down 2.4% - What's Next? - Daily Political

AbbVie Adjusts 2026 Profit Outlook After $10.9 Billion Apogee Buy, Reports Strong Q2 Results, ETPharma

Best Pharmaceutical Stocks To Keep An Eye On - July 29th - Markets Daily

4,955 Shares in AbbVie Inc. $ABBV Purchased by Montchanin Asset Management LLC

Segall Bryant & Hamill LLC Takes $43.63 Million Position in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Posts Earnings Results, Beats Estimates By $0.04 EPS - Daily Political

AbbVie Inc. $ABBV Shares Acquired by Capasso Planning Partners LLC - Daily Political

Glenmede Trust Co. NA Has $74.19 Million Stake in AbbVie Inc. $ABBV - Daily Political

Why AbbVie Stock Slumped Today

AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - Zolmax

AbbVie (NYSE:ABBV) Announces Earnings Results, Beats Estimates By $0.05 EPS - Zolmax

AbbVie's Skyrizi and Rinvoq Launches Support Lengthy Patent Protection and a Wide Moat | Morningstar

AbbVie (NYSE:ABBV) Releases Earnings Results, Beats Estimates By $0.05 EPS

AbbVie (NYSE:ABBV) Stock Price Down 2.4% - Time to Sell? - Zolmax

Health Care Down on Rotation Out of Defense - Health Care Roundup | Morningstar

AbbVie (NYSE:ABBV) Trading Down 2.4% - Should You Sell?

AbbVie Inc (ABBV) (Q2 2026) Earnings Call Highlights: Robust Growth Driven by Skyrizi and ...

XLV vs. IHE: Which Healthcare ETF Is the Better Buy?

Which Healthcare ETF Is the Better Buy: Fidelity's FHLC or Invesco's Equal-Weight RSPH?

AbbVie Q2 Earnings Call Highlights

AbbVie Beats but Cuts Guidance on $10.9 Billion Acquisition

Best Medical Stocks To Follow Now - July 31st - Stock Observer

AbbVie Lowers Outlook to Account for Acquisition, as 2Q Profit Jumps | Morningstar

AbbVie shares fall on earnings miss and weak guidance

AbbVie Trims FY26 Adj. EPS Outlook - Update

AbbVie Profit Rises In Q2

AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates

AbbVie (NYSE:ABBV) Issues Q3 2026 Earnings Guidance - Stock Observer

Pharmaceutical Stocks To Add to Your Watchlist - July 31st - Daily Political

AbbVie Q2 26 Earnings Conference Call At 9:00 AM ET

AbbVie Inc. $ABBV Shares Sold by Vestor Capital LLC

AbbVie Inc. $ABBV Shares Purchased by Groupe la Francaise

FinArc Investments Inc. Makes New Investment in AbbVie Inc. $ABBV

Western Wealth Management LLC Grows Stock Position in AbbVie Inc. $ABBV - Stock Observer

FinArc Investments Inc. Takes $1.15 Million Position in AbbVie Inc. $ABBV - Stock Observer

AbbVie News | Markets Insider

Friday's big stock stories: What's likely to move the market in the next trading session

AbbVie (NYSE:ABBV) Stock Price Down 2.2% - Here's Why

Best Pharmaceutical Stocks To Research - July 30th - Stock Observer

AbbVie Inc. $ABBV Shares Acquired by Hamilton Wealth LLC

Bank of America Corp DE Reduces Stock Position in AbbVie Inc. $ABBV - Markets Daily

Bank of America Corp DE Trims Position in AbbVie Inc. $ABBV - Stock Observer

Pharmaceutical Stocks To Watch Today - July 27th - Daily Political

Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression

Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now

Investors Buy Large Volume of AbbVie Call Options (NYSE:ABBV)

AbbVie (ABBV) Stock: Rises as RINVOQ Wins EU Approval for Severe Hair Loss

AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?

AbbVie Gets Europe OK for Rinvoq in Vitiligo, Alopecia Areata | Morningstar

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo | Morningstar

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata | Morningstar

AbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata

AbbVie Wins EC Approval For Rinvoq In Non-Segmental Vitiligo

AbbVie Inc. $ABBV Shares Bought by Opal Capital LLC

AbbVie (ABBV) Expected to Announce Quarterly Earnings on Friday - Zolmax

Encore Global Management LP Takes $544,000 Position in AbbVie Inc. $ABBV

AbbVie (ABBV) Stock May Be Mispriced On Its 172% Run

AbbVie Secures EC Nod For RINVOQ In Severe Alopecia Areata

Amundi Has $2.33 Billion Holdings in AbbVie Inc. $ABBV

Pharmaceutical Stocks To Add to Your Watchlist - July 28th - Stock Observer

AbbVie Inc. $ABBV Shares Acquired by Lazard Asset Management LLC - Stock Observer

Encore Global Management LP Invests $544,000 in AbbVie Inc. $ABBV - Stock Observer

California State Teachers Retirement System Sells 62,377 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer

Goldman Sachs uncovers key AbbVie stock signals before earnings

De-escalation trials in multiple myeloma: past, present and future

AbbVie (NYSE:ABBV) Trading 2.6% Higher - What's Next?

3 Major Reasons for Investors to Buy AbbVie Stock Before July 31st

Pharmaceutical Stocks To Add to Your Watchlist - July 28th - Daily Political

Empowered Funds LLC Acquires 78,374 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie (ABBV) Launches Boey In Europe With A Different Take On Wrinkle Injectables

Johnson & Johnson (NYSE:JNJ) Trading 1.1% Higher - Should You Buy? - Markets Daily

The Engine Behind ABBV Stock Has Real Parts